Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,280.00
-25.00 (-1.08%)
At close: Jul 18, 2025, 3:30 PM KST
Yungjin Pharm. Company Description
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products.
The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm.
Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm.
Co., Ltd. operates as a subsidiary of KT&G Corporation.
Yungjin Pharm. Co., Ltd.
| Country | South Korea |
| Founded | 1952 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 574 |
| CEO | Chae-Joon Lee |
Contact Details
Address: Jamsil Company Building Seoul, 05510 South Korea | |
| Phone | 82 2 2041 8200 |
| Website | yungjin.co.kr |
Stock Details
| Ticker Symbol | 003520 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003520004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chae-Joon Lee | Chief Executive Officer and President |